feed,title,long_url,short_url
Benzinga,Merck To Buy Late-Stage COVID-19 Treatment Company OncoImmune For $425M In Cash,https://www.benzinga.com/general/biotech/20/11/18488474/merck-to-buy-late-stage-covid-19-treatment-company-oncoimmune-for-425m-in-cash,https://j.mp/339a4hD
